BBlogFlow

Congo's Ebola outbreak has killed more than 4,000 as health workers protest delayed payment - Castanet

·Oct 2, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

This article is an excerpt. To read the full content, visit the original source. Castanet

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

New CDC report details deadly toll of delayed measles complication in kids - CIDRAP

[Editor's note: The authors of the report were misidentified in the original version of this story. The story has since been corrected. CIDRAP News regrets the error.]Measles is sometimes dismissed as an unserious disease or ‘just a rash.’ But the highly contagious virus can cause serious illness not just during initial infection but years later, after patients appear to have made a full recovery. This delayed complication, a rare, almost invariably fatal brain disease known as subacute sclerosing panencephalitis (SSPE), is highlighted in a new report published yesterday in Emerging Infectious Diseases. For the report, researchers in the Philippines looked at 20 children from that country, where measles outbreaks occurred in 2010–11, 2013, and 2018-19. The most recent outbreak was the largest in the World Health Organization Western Pacific Region. All children in the report were admitted to the pediatric hospital in Quezon City from 2007 through 2022. Larger wave of SSPE may be on horizonAll four children with estimated measles infection dates corresponding to the 2018-19 outbreak were hospitalized between 2020 and 2022, two to three years after their initial infections.

CIDRAP·

WHO warns of ‘devastating consequences’ due to delayed aid entry into Gaza - Al Jazeera

The WHO’s representative in Palestine calls on Israeli authorities to “release the pressure on medical supplies”. Repeated delays in bringing life-saving medicines, prosthetics and other supplies from Israel into Gaza risk having “devastating consequences” for Palestinians who urgently need them, the World Health Organization (WHO) has said. Approved aid can enter Gaza only through Kerem Shalom, at the southern tip of the territory, while Rafah, also in the south, is open only for limited movement of people, including patients needing medical treatment abroad, the WHO said on Friday. Recommended Stories list of 4 itemslist 1 of 4Israel could’ve ended Gaza war, freed captives sooner: Israel ex-negotiatorlist 2 of 4Israeli general: Gaza captives could have been freed a year earlierlist 3 of 4Israeli air attack on Gaza City apartment kills at least fivelist 4 of 4FAO official says he lost his job for criticising Israeli policies in Gazaend of list“A truck full of non-priority supplies or the right supplies arriving too late, doesn’t save lives. That’s the question that actually matters,” Reinhilde Van De Weerdt, the WHO’s representative in Palestine, said.

Al Jazeera·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·